Recruiting OBSERVATIONAL NCT05258448

COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA) (COLA)

The Effect of Radiotherapy on the Heart in Loco-regional Advanced NSCLC Patients Treated With Definitive Radiotherapy Measured by Cardiac MR

Sponsor: Odense University Hospital

Conditions Cardiac Disease Cardiac Toxicity Lung Cancer Stage II Lung Cancer Stage III Radiation Toxicity

Interventions Chemoradiotherapy

Updated 4 times since 2022 Last updated: Dec 5, 2023 Started: Aug 31, 2015 Primary completion: Aug 31, 2024 Completion: Oct 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cardiac Disease and Cardiac Toxicity and is currently actively recruiting participants. Odense University Hospital leads this study, which shows 4 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jan 2024 — Jul 2024 [monthly]

Recruiting
Mar 2022 — Jan 2024 [monthly]

Recruiting

First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Odense University Hospital

Data source: Odense University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Odense C, Denmark